Radius Health develops drug therapies for osteoporosis and women’s health.
Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health.The company's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life.Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging.Radius's scientific leadership includes some of the world's leading researchers in the fields of bone metabolism, endocrinology, and medicinal chemistry, and the company has a broad foundation in nuclear hormone receptors.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 25, 2013 | Private Equity(PE) | $43M | 1 | — | — | Detail |
Nov 20, 2008 | Series C | $15M | 1 | MPM Bio IV NVS Strategic Fund | — | Detail |
Sep 17, 2007 | Series C | $10M | 1 | MPM Bio IV NVS Strategic Fund | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 30, 2018
GoHenry
|
Equity Crowdfunding | £6.28M | Children | — |
Oct 4, 2017
Seedrs
|
Equity Crowdfunding | £6M | Crowdfunding | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
MPM Bio IV NVS Strategic Fund | — | Private Equity(PE) |